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The term “hereditary spastic paraplegia” (HSP) refers to a genetically and clinically diverse group of disorders
whose primary feature is progressive spasticity of the lower extremities. The condition arises because of degeneration
of the longest motor and sensory axons on the spinal cord, which appear to be most sensitive to the underlying
mutations. The marked genetic heterogeneity in HSP, with 20 loci chromosomally mapped and eight genes now
identified, suggests that a number of defective cellular processes may be shown to result in the disease. Although
previous studies have suggested a mitochondrial basis for at least one form of the disease, a mechanism common
to a number of the other genes mutated in HSP has remained elusive until now. The identification of the most
recent genes for the condition suggests that aberrant cellular-trafficking dynamics may be a common process
responsible for the specific pattern of neurodegeneration seen in HSP.
Introduction
The term “hereditary spastic paraplegia” (or “hereditary
spastic paraparesis”) (HSP) is used to describe a group of
clinically heterogeneous neurodegenerative disorders in
which the predominant feature is progressive spasticity
associated with mild weakness of the lower limbs, which
may be accompanied by bladder disturbances and subtle
vibratory sense impairment (McDermot et al. 2000).
These disorders are classified as either “pure” (or “un-
complicated”), when the above features occur in isolation,
or “complicated,” in the presence of additional neuro-
logical manifestations, such as mental retardation, extra-
pyramidal symptoms, deafness, or optic neuropathy.
First described in the latter part of the 19th century
(Seeligmuller 1876; Strumpell 1880), HSP remains a
poorly understood condition. Neuropathological analy-
sis of tissues from patients with pure forms of HSP has
revealed axonal degeneration of the distal portions of the
corticospinal tracts, the fasciculus gracilis, and the spi-
nocerebellar tracts, which together constitute the longest
motor and sensory axons of the CNS (Schwarz and Liu
1956; Behan and Maia 1974). A specific pattern of de-
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generation is seen in HSP, during which the cell bodies
remain largely intact while the degeneration is principally
limited to the cell axon and may be a “dying back” ax-
onopathy, beginning distally and proceeding towards the
cell body (Schwarz and Liu 1956). Despite the large and
ever-increasing number of loci mapped for the various
forms of HSP (table 1) and the identification of eight
genes to date, a clear basis for most forms of HSP remains
elusive. The identification of the causative genes and
pathogenic mechanism(s) responsible for the specific pat-
terns of neurodegeneration presents the initial challenge.
In this article, we review the genes known to cause HSP
and emphasize how recent discoveries suggest that de-
fective trafficking may be a mechanism common to sev-
eral forms of HSP.
The X-Linked Genes
Two X-linked genes—L1 cell adhesion molecule
(L1CAM) and proteolipid protein (PLP1)—were the first
HSP genes to be identified, both of which may be mutated
to produce a complicated HSP phenotype. PLP1 muta-
tions may additionally lead to pure HSP (Jouet et al. 1994;
Saugier-Veber et al. 1994). The varying complicated phe-
notypes associated with L1CAM mutations are often re-
ferred to as the “CRASH syndrome” (corpus callosum
hypoplasia, retardation, adducted thumbs, spastic para-
plegia, and hydrocephalus) (Fransen et al. 1995). The
L1CAM gene encodes a transmembrane glycoprotein
with extracellular immunoglobulin and fibronectin type
II repeats, which mediates cell adhesion and neurite
growth. Neuropathological studies and the use of trans-
genic animal models have suggested that this molecule is
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Table 1
Summary of the Known HSP Loci and Genes
Symbol/Locus
Cytogenetic
Location Inheritance Protein
OMIM
Number HSP Syndrome(s)
L1CAM (SPG1) Xq28 X-linked L1CAM MIM 312900 Complicated
PLP1 (SPG2) Xq28 X-linked PLP1 MIM 312920 Complicated (rarely pure)
SPG3A 14q11-q21 Autosomal dominant Atlastin MIM 182600 Pure
SPG4 2p22 Autosomal dominant Spastin MIM 182601 Mainly pure
SPG5A 8q Autosomal recessive MIM 270800 Pure
SPG6 15q11.1 Autosomal dominant MIM 600363 Pure
SPG7 16q24.3 Autosomal recessive Paraplegin MIM 600146 Pure and complicated
SPG8 8q23-q24 Autosomal dominant MIM 603563 Pure
SPG9 10q23.3-q24.2 Autosomal dominant MIM 601162 Complicated
SPG10 12q13 Autosomal dominant KIF5A MIM 604187 Pure
SPG11 15q13-q15 Autosomal recessive MIM 604360 Pure
SPG12 19q13 Autosomal dominant MIM 604805 Pure
SPG13 2q24-q34 Autosomal dominant HSP60 MIM 605280 Pure
SPG14 3q27-q28 Autosomal recessive MIM 605229 Complicated
SPG15 14q22-q24 Autosomal recessive MIM 606859 Complicated
SPG16 Xq11.2 X-linked MIM 300266 Complicated
SPG17 (Silver syndrome) 11q12-q14 Autosomal dominant MIM 270685 Complicated
SPG19 9q33-q34 Autosomal dominant MIM 607152 Pure
SPG20 (Troyer syndrome) 13q12.3 Autosomal recessive Spartin MIM 275900 Complicated
NOTE.—Data taken from the HUGO Gene Nomenclature Committee database, where SPG3A, SPG5B, and SPG18 are listed as “reserved.”
required for normal development of the corticospinal tract
(reviewed by Casari and Rugarli 2001), and recent data
suggest a function for L1CAM in potentiation of neuronal
migration (Thelen et al. 2002).
PLP1 encodes one of the major components of myelin
and is mutated in complicated and (rarely) in pure forms
of HSP. Mutations in PLP1 are also responsible for Pel-
izaeus-Merzbacher disease (Saugier-Veber et al. 1994),
which is characterized by significant hypomyelination of
the CNS with a reduced number of mature oligodendro-
cytes. An understanding of the pathogenic mechanisms
underlying these conditions has been provided by the gen-
eration of knockout mice lacking PLP1. Perhaps surpris-
ingly, these animals have essentially normal CNS function
but assemble compact myelin sheaths and ultimately de-
velop widespread axonal swelling and degeneration (Grif-
fiths et al. 1998). Consequently, a lack of PLP1 protein
does not cause the dysmyelination seen in PMD, and the
axonal defect is best explained by a deficiency in oligo-
dendroglial function. The fact that this is associated with
the accumulation of membranous dense bodies and mi-
tochondria suggests that axonal transport is impaired
(Griffiths et al. 1998).
The Mitochondrial Story
A different mechanism of action has been proposed for
the paraplegin gene (SPG7), the third HSP gene to be
identified, which is mutated to produce both complicated
and pure forms of autosomal recessive HSP (Casari et al.
1998). Paraplegin is a mitochondrial metalloproteasewith
strong homology to the yeast mitochondrial ATPases
afg3, rca1, and yme1. It contains an AAA (ATPases as-
sociated with diverse cellular activities) domain common
to the AAA proteins (Patel and Latterich 1998), a group
of molecules possessing a range of functions that include
protein degradation and trafficking and organelle bio-
genesis. Mitochondrial AAA proteins display chaperone-
like activity in functions such as ensuring the specificity
of proteolysis and the activation of respiratory chain com-
plexes (Leonhard et al. 1999). Consistent with a role for
paraplegin in mitochondrial function, muscle biopsies ob-
tained from some patients with paraplegin mutations
show typical signs of mitochondrial disease (Casari et al.
1998). These include ragged-red fibers, intense succinate-
dehydrogenase–stained areas, and cytochrome-oxidase–
negative fibers. Furthermore, the degree of mitochondrial
abnormality correlates with the severity of the disease.
Taken together, these findings suggest that a mitochon-
drial-based mechanism underlies this form of the disorder.
Very recent preliminary reports of electron microscopy
studies in mice lacking paraplegin reveal that, long before
degeneration, the axons are filled with abnormal mito-
chondria. Subsequently, swollen axons containing accu-
mulated organelles and neurofilaments are seen, which
suggests that mitochondrial dysfunction may lead to ax-
onal degeneration by impairing axonal transport (Ferrei-
rinha et al. 2001).
A single missense mutation (V72I) in heat shock protein
60 (Hsp60, also known as “chaperonin”), a mitochon-
drial chaperone not structurally related to paraplegin,
has recently been identified in a dominant form of HSP
(SPG13; Hansen et al. 2002). The Escherichia coliHSP60
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orthologue GroEL is essential for growth under a variety
of conditions (Fayet et al. 1989). Through use of a com-
plementation assay, wild-type HSP60, but not HSP60
(V72I), was shown to support growth of strains of E. coli
in which the endogenous orthologous genes had been de-
leted (Hansen et al. 2002). The mechanism of action of
this mutation is unclear. The dominant inheritance of this
form of HSP may arise through haploinsufficiency caused
by a lowering of overall chaperonin activity. Alternatively,
mutant subunits may perturb the allosteric coupling of
wild-type molecules, thus exerting a dominant negative
effect. Because of the discovery of mutations within genes
encoding chaperones and their action as phenotype mod-
ulators, a role for chaperones is increasingly recognized
in a range of neurodegenerative conditions, including au-
tosomal recessive spastic ataxia of Charlevoix-Seguenay
(MIM 270550) and amyotrophic lateral sclerosis (Sla-
votinek and Biesecker 2001), which have some similarities
with HSP.
Transport Mechanisms in Axons: an Overview
It is of particular interest that the axonal degeneration
in HSP is maximal in the longest tracts. Because of the
length of their axons and their highly polarized archi-
tecture, neurons are highly dependent on an intricate
system of transport designed to ensure correct targeted
delivery of cell components (reviewed by Almenar-Quer-
alt and Goldstein 2001). Important components of the
cytoskeleton, along which different motor proteins move
their cargoes at different rates, include polarized micro-
tubules, utilized for long-range transport, and actin, util-
ized for short-range transport (reviewed by Apodaca
2001). Fast and slow axonal transport occurs along mi-
crotubules. Slow axonal transport, by which many cy-
toskeletal proteins move, is thought to occur only in the
anterograde direction (i.e., towards the plus end of the
microtubule). Fast anterograde transport, powered by
kinesin motor proteins, is used for the transport of ves-
icles, membranes, and membranous organelles such as
mitochondria. Fast retrograde transport (i.e., towards
the minus end of the microtubule) is powered by dynein
motor proteins and delivers endosomes, other organ-
elles, and neurotrophic signals back to the cell bodies.
Endosomes function as a central sorting site for both
the biosynthetic and degradative pathways. Endocytosed
substances move from early endosomes either to tubular
recycling endosomes along the actin cytoskeleton, or via
endosomal carrier vesicles/multivesicular bodies to late
endosomes and then to lysosomes along the microtu-
bule cytoskeleton (Matteoni and Kreis 1987; Gruenberg
2001). Newly synthesized lysosomal proteins also pass
through an endosomal intermediate en route from the
trans-Golgi to the lysosome (Babst et al. 1998). Studies
of rat hippocampal neurons have allowed the clear iden-
tification of two apparently distinct classes of endosomes
in axons: stationary round-oval endosomes and highly
mobile tubulovesicular endosomes, which move along
microtubules in both directions (Prekeris et al. 1999).
Spartin and Endosomal Trafficking
Until recently, there was little evidence to link the func-
tions of any of the known HSP genes. However the recent
identification of spartin (spastic paraplegia autosomal re-
cessive Troyer syndrome), mutated in Troyer syndrome
(TRS; SPG20), has suggested that the biochemical roles
of some genes mutated to result in HSP may be related
(Patel et al. 2002). TRS is an autosomal recessive com-
plicated form of HSP associated with dysarthria and distal
amyotrophy, present at high frequency in the Amish pop-
ulation of the United States (Cross and McKusick 1967).
We have now identified 125 cases of TRS in the Amish
community, all of which can be linked together to produce
a single extensive pedigree. A single homozygous base pair
deletion (1110delA) in exon 4 of spartin, located on chro-
mosome 13q12.3, accounts for all cases of TRS within
this population (Patel et al. 2002). Multiple sequence
alignment reveals that spartin contains three novel do-
mains, two of which are located in the C-terminal portion
and are present in plants (data not shown). At present,
the only functional information reported for these do-
mains concerns their expression under stress conditions
such as dehydration and senescence.
The N-terminal portion contains a recently described
ESP domain, so named because it was identified in three
molecules: End13/Vps4, SNX15 (sorting nexin 15), and
PalB (Phillips et al. 2001). The N-terminal portion of the
ESP domain has similarity to the tetratricopeptide repeat
homology consensus sequence (Phillips et al. 2001), which
mediates protein-protein interactions (Blatch and Lassle
1999). Our multiple alignment studies reveal that the
length of the ESP domain can be slightly extended from
that previously described and that it is present in a range
of other molecules, many of which have a well-defined
and consistent biochemical role (fig. 1). The sorting nexins
are a family of mammalian proteins whose yeast or-
thologues have been identified as essential components
in intracellular protein trafficking. Sorting nexin 15
(SNX15) is a recently discovered SNX that, on the basis
of morphological and biochemical data, is also thought
to play a crucial role in trafficking through the endocytic
pathway, although no obvious orthologue in yeast orCae-
norhabditis elegans has been found (Barr et al. 2000; Phil-
lips et al. 2001). Immunofluorescence staining in COS7
cells has revealed that, although predicted to be soluble,
SNX15 is found both within the cytosol and on mem-
branes (Barr et al. 2000). Immunofluorescence staining of
endogenous SNX15 showed that it resides within small
puncta that partially colocalize with proteins that mark
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Figure 1 Multiple sequence alignment of selected members of the ESP (MIT) domain–containing proteins. Sequences are indicated using
their database accession number followed by the starting and the ending residues of the domain and by the species. The consensus present in
70% of the sequences is given below the alignment; residues and colors are as follows: h (hydrophobic, blue), l (aliphatic, blue), K (lysine),
p (polar, yellow), and R (arginine). Plus signs () indicate conserved, positively charged residues (lysine and arginine), which are colored in red
in the alignment; minus signs () indicate conserved, negatively charged residues, which are indicated in pink. The secondary structure prediction
(“Sec.Str.Pred.”) at the bottom of the alignment is derived from the alignment (H p helix predicted with expected average accuracy 182%; h
p helix predicted with expected average accuracy !82%). Abbreviations: Hs, Homo sapiens; Mm, Mus musculus; and Sc, Saccharomyces
cerevisiae.
or cycle through early endosomes. Overexpression of re-
combinant SNX15 in several cell types resulted in the
appearance of abnormal structures, disrupting the organ-
ization of endosomes and leading to the formation of
abnormal membrane-limited structures containing mark-
ers from early endosomes, late endosomes, and lysosomes.
Taken together, these data suggest that SNX15 may nor-
mally reside on a subpopulation of early endosomes and
that its overexpression causes abnormal trafficking of pro-
teins from the plasma membrane to the trans-Golgi net-
work or to recycling endosomes (Barr et al. 2000; Phillips
et al. 2001). The overexpression of SNX15 also slowed
the internalization of transferrin and furin, proteins en-
docytosed through clathrin-coated pits, indicating that
SNX15 may affect clathrin-mediated endocytosis (Barr et
al. 2000).
In addition to the above molecules, we have identified
the ESP domain in yeast vacuolar protein sorting factor
4 (Vps4p), in its mammalian orthologues VPS4 and
SKD1, and in spastin (commonly mutated in HSP; see
below), which are all closely related ATPases belonging
to subfamily 7 of the AAA group of proteins (Babst et
al. 1997; Beyer 1997; Hazan et al. 1999; Yoshimori et
al. 2000). Yeast Vps4p is an essential component of the
intracellular protein transport machinery, in which it is
required for the efficient transport of newly synthesized
carboxy-peptidase Y from the Golgi network to the vac-
uole, the yeast counterpart of the animal lysosome (Babst
et al. 1998). Mutant cells exhibit defects in several in-
tracellular trafficking routes. Through use of a mutated
form of Vps4p that is unable to bind to or hydrolyze
ATP, it was shown that Vps4p associates transiently with
an endosomal compartment in an ATP-dependent pro-
cess (Babst et al. 1998). The ATP-hydrolysis–deficient
Vps4p is directed to the class E compartment, thought
to be an aberrant endosomal structure containing ma-
terial from both the endocytic and biosynthetic path-
ways (Babst et al. 1998). Vps4p ATPase may therefore
catalyze the “uncoating” of a protein complex asso-
ciated with the cytoplasmic face of the endosomal
membrane, in a process that is required for normal en-
dosomal morphology and sorting (Babst et al. 1998).
Like SNX15, Vps4p shows no obvious membrane-bind-
ing regions. It does, however, contain a putative 34–
amino acid coiled-coil motif (Scheuring et al. 2001) that
corresponds almost exactly to the terminal portion of
the ESP domain. Deletion of a region including this
coiled-coil motif abolishes the membrane association,
thus implicating the ESP domain in the process of bind-
ing to endosomal membranes (Babst et al. 1998).
Numerous lines of evidence point to a similar role for
the mammalian orthologues of Vps4p in protein traffick-
ing and the regulation of endosomal morphology. Hu-
mans harbor two nonallelic Vps4p orthologues (VPS4-A
and VPS4-B) that share a high degree of sequence simi-
larity throughout the polypeptides (Scheuring et al. 2001).
Heterologous expression of the human genes in Vps4p
mutant yeast leads to suppression of the temperature-
sensitive growth defect. Moreover, both human proteins
associate with endosomal compartments in yeast when
mutated to the ATPase-defective state (Scheuring et al.
2001). However, unlike yeast Vps4p, which binds exclu-
sively to the class E perivacuolar compartment, ATPase-
defective mammalian VPS4-A binds to multiple endosom-
al compartments (Bishop and Woodman 2000). SKD1, a
mouse orthologue of VPS4 that most closely resembles
human VPS4-B (Scheuring et al. 2001), is also involved
in this process and is believed to associate transiently with
membranes. Overexpression of mutant SKD1 in cultured
mammalian cells results in the defective uptake of trans-
ferrin and low-density lipoprotein, due to a loss of their
respective cell surface receptors (Yoshimori et al. 2000).
Electron microscopy reveals exaggerated multivesicular
vacuoles with numerous tubulovesicular extensions, sug-
gesting that SKD1 is likely to be involved in the regulation
of endosome morphology and transport. Very recent data
suggest that the specific stage of endosomal trafficking for
which SKD1 is required is the formation of autolysosomes
in the late stages of the autophagic pathway (Nara et al.
2002). Finally, the ESP domain is also contained within
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the recently identified human RPK118, found to colo-
calize with early endosomes (Hayashi et al. 2002).
Spastin and Microtubules
Notably, the ESP domain present within the endosom-
al trafficking molecules was also detected in the N-
terminus of spastin (SPG4), the gene most commonly
mutated in autosomal dominant HSP (Hazan et al.
1999). A recent study has shown that wild-type spastin
interacts transiently with microtubules and is likely to
be involved in microtubule dynamics (Errico et al. 2002).
Overexpression of spastin in COS-7 and HeLa cells re-
sults in a microtubule-disassembly phenotype. These
changes are not seen in cells transfected with mutant
spastin and are specific to microtubules. However, spas-
tin mutants, including most disease-causing AAA cas-
sette missense mutants and a protein lacking the entire
AAA cassette, are able to constitutively bind to micro-
tubules, leading to a redistribution of the microtubule
array. This suggests that spastin microtubule binding is
ATPase-dependent, a finding analogous to the Vps4/
SKD1 studies in which transient binding to membranes
is also dependent on ATPase function. Although mis-
sense and truncating mutations have been shown to
cause similar phenotypes, implying that haploinsuffi-
ciency is the pathogenic mechanism (Fonknechten et al.
2000), the finding that spastin mutants are able to con-
stitutively bind microtubules raises the possibility of a
dominant negative effect asserted by at least some spas-
tin mutations. However, an important issue is the ap-
parent instability of aberrant mRNA in truncating mu-
tations (Svenson et al. 2001), which argues against such
a dominant negative effect.
Studies using artificial spastin mutants indicate that
the microtubule-binding capability of this molecule re-
sides within its N-terminal region, although no func-
tional domains in this region have been identified (Errico
et al. 2002). Since the ESP domain lies within the N-
terminal portion of spastin and no other domains in this
region have been discovered, it seems possible that ESP
provides the structural framework for microtubule in-
teraction. However, the domain is also present within
the Vps4p orthologues, as well as within SNX15 and
RPK118, which have not been linked to microtubules
but are involved in endosome modulation. Because the
term “ESP” does not relate to its function and given its
presence in the endosome-associating molecules and
the microtubule-binding spastin, we propose the alterna-
tive descriptive term “MIT” for this domain (contained
within microtubule-interacting and endosomal traffick-
ing molecules).
Atlastin and the Dynamins
Additional support for defective trafficking as the basis
for some forms of HSP is provided by the identification
of three different mutations in atlastin (SPG3A) that result
in dominantly inherited early-onset HSP (Zhao et al.
2001b; Muglia et al. 2002). Although the atlastin gene
shares no homology with spartin or spastin, it encodes a
product possessing structural homology with members of
the dynamin family of large GTPases and has been ten-
tatively assigned to this group. Dynamins play essential
roles in a wide variety of vesicle trafficking events that
are important for the action of neurotrophic factors and
during neurotransmission (reviewed by McNiven et al.
2000). Seminal in vitro studies have shown that, under
the correct conditions, dynamin self-assembles to form
stacks of helical ring structures resembling the necks of
invaginated coated pits, supporting a role for dynamin in
the constriction and scission of budding vesicles (Hinshaw
and Schmid 1995). Moreover, dynamin has been impli-
cated in multiple clathrin-dependent and -independent
vesicle-mediated processes, in both endocytic and secre-
tory pathways (reviewed by McNiven et al. 2000). In
addition to its involvement in the early stages of endocytic
vesicle formation, dynamin is also thought to play a role
in the later stages of membrane trafficking and may par-
ticipate in the formation and liberation of coated vesicles
from secretory compartments.
Kinesin Mutation Found in HSP
New support for defective trafficking in some forms
of HSP is provided by the most recently identified caus-
ative gene. In the study by Reid et al. (2002 [in this
issue]), a mutation in a kinesin heavy chain gene,KIF5A,
has been identified in a family with chromosome 12q–
linked HSP (SPG10). KIF5A, which does not contain the
MIT (ESP) domain, forms part of a heterotetrameric
protein motor complex that transports cargoes along
microtubules in an anterograde direction (Goldstein and
Yang 2000). The mutation identified in this family oc-
curs in an invariant asparagine residue (N256S) located
within the motor domain of the molecule, which has
been previously identified as crucial to motor function
in biochemical studies of kinesin proteins. Biochemical
properties of a yeast mutant with a substitution in the
homologous amino acid position (N650K) suggest that
the human mutation may result in a dominant-negative
version of the neuronal kinase-I motor (Hoyt et al.
1993).
Loss-of-function mutations in kinesin heavy chain
genes associated with neurological disorders have been
identified in a range of species (Reid et al. 2002). In par-
ticular, disruption of the murine gene encoding kinesin
motor protein Kif1bb results in a “staggering gait” phe-
notype in adult heterozygous animals (Zhao et al. 2001a)
with reduced synaptic vesicle precursors. KIF1Bb muta-
tions in humans result in Charcot-Marie-Tooth type 2A
(MIM 118210), a common inherited peripheral neurop-
athy characterized by weakness and atrophy of distal
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muscles, depressed tendon reflexes, and mild sensory loss
(Zhao et al. 2001a). The Q98L mutation identified in
KIF1Bb was shown to disrupt the motor function of the
protein. Consequently the levels of synaptic vesicle pro-
tein cargoes, such as synaptotagmin and SV2, were spe-
cifically decreased in the peripheral axons of Kif1B het-
erozygous mice. Neurophysiological studies of Kif1B
heterozygous mice showed the pathology to be an ax-
onopathy rather than demyelination (Zhao et al. 2001a).
In addition to the mutations in the kinesin heavy chain
genes, mouse kinesin light chain (KLC) mutants exhibit
overt movement defects and small size (Rahman et al.
1999). Their sensory and motor neurons display alter-
ations in the intracellular location of various cellular
components. Thus, kinesin mutation studies clearly sup-
port a role for defective microtubule-mediated traffick-
ing leading to axonal degeneration in the peripheral as
well as the central nervous system, highlighting the uni-
versal need of long axons for intact transport systems.
Overview
Our aim in this review has been to highlight common
ground between the likely functions of the genes mutated
in HSP. The involvement of aberrant mitochondrial pro-
cesses in neurodegenerative diseases is well established
(Orth and Schapira 2001), and paraplegin and HSP60
mutations offer evidence for the involvement of this
mechanism in HSP. The preferential degeneration of long
axons may be explained by their high energy require-
ments and may arise as a result of inadequate fueling of
axonal transport. With the recent identification of new
genes underlying different forms of HSP, evidence is ac-
cumulating to link defective trafficking dynamics with
the neurodegeneration seen in the disease. A mutated
kinesin, part of the anterograde transport machinery,
provides the most direct evidence. Spastin, the first dom-
inant HSP gene identified, binds microtubules, which are
the key to axonal transport. A potential role of endo-
somal trafficking is highlighted by the discovery of the
MIT (ESP) domain, present in endosomal-associated
molecules, in the recently identified spartin. The presence
of the MIT (ESP) domain in spastin suggests that the
function of these two proteins is related to some extent.
Atlastin, the second dominant HSP gene identified, may
well have a function in vesicular transport. Notably, it
is interesting that mice lacking paraplegin, a mitochon-
drial protein, or PLP1, a myelin component, also display
defects in axonal transport.
Defective trafficking has also been implicated in other
neurodegenerative diseases. Alsin is mutated in amyotro-
phic lateral sclerosis 2 (MIM 205100), which has a num-
ber of features in common with HSP, and is thought to
be involved in membrane-proximity activities of small
GTPases that modulate microtubule assembly, membrane
organization, and trafficking in neuronal cells (Yang et
al. 2001). The genes for chorea-acanthocytosis, an au-
tosomal recessive disorder characterized by hyperkinet-
ic movements and abnormal erythrocyte morphology
(caused by mutations in CHAC [MIM 200150]), and
Niemann-Pick type C1, a fatal neurovisceral disorder
caused by mutations in NPC1 (MIM 257220), are also
thought to be involved in this mechanism (Rampoldi et
al. 2001; Zhang et al. 2001).
Until recently, the wide range of possible functions for
the limited number of genes known to underlie HSP
seemed at loggerheads with the specific pattern of neu-
ronal damage seen in this condition. However, these pre-
liminary studies are beginning to provide a functional
link between different forms of the condition. Trafficking
along microtubules is a vital process by which the cell
transfers a wide range of constituents from one region
to another, and long axons may be particularly suscep-
tible to its disruption. This could explain why mutations
in widely expressed genes, such as spastin and spartin,
lead to degeneration of very specific cell types. In simple
terms, it would appear that mutations in genes involved
in these processes may result in road blocks that prevent
essential cargoes from reaching their correct cellular des-
tination. Additional functional studies are now required
to explore the biochemical roles of these molecules in
more detail, in order to confirm or refute the defective
transportation hypothesis. The rapid pace of this re-
search, which now includes the production of animal
models of the disease and the ability to study transport
in living cells, offers real hope that confirmation of the
biochemical pathophysiology of HSP may soon be at
hand. With the number of HSP genes identified now in-
creasing, new diagnostic tools are becoming available to
substantiate the clinical diagnosis of HSP, and a molec-
ular-based reclassification of this group of conditions may
ultimately be appropriate. In years to come, additional
studies of the pathogenic mechanisms will open the
possibility for creating treatments for this group of
conditions.
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of Charlevoix-Seguenay [MIM 270550], Charcot-Marie-
Tooth type 2A [MIM 118210], amyotrophic lateral sclerosis
2 [MIM 205100], CHAC [MIM 200150], and NPC1 [MIM
257220])
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